~~<i id='8EB32A9B31'><strike id='8EB32A9B31'><tt id='8EB32A9B31'><pre id='8EB32A9B31'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：entertainment 2025-09-05 11:30:59 - browse：4872

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： 'Cuddling' is just what the doctor ordered for a 200

focus

hotspot

explore

leisure time

focus

CommonSpirit,oneofthecountry’sbiggesthealthsystems,keepsgrowingitshospitalcountanddebt,evenasitloses

WSS

Calls for Trump's election interference trial to be televised part of long debate

It's been 20 years since Dolly the sheep. Where's my clone?

Experts study whether long Covid risk adds up with each reinfection

Scientists find bacteria from stomach of ancient iceman

Senate HELP committee spars over health care workforce policies

Russian court extends detention of American musician

focus

leisure time

focus

Moonlake's readout produced a cash windfall. Risks remain

Eat, drink, but be wary — 4 foods that interact with medications

Walensky prepares to leave CDC — and Congress — behind

What Congress can do to address the rural doctor shortage

George Santos makes 1st court appearance after pleading not guilty to 13 counts

How AI helped researchers track recovery from depression

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why are Kaiser Permanente staff considering a strike?

Alkermes shareholders re

How Vertex's cystic fibrosis drug is changing patients' lives

focus

Hearing on Medicare drug price negotiation gets unusually heated

What Congress can do to address the rural doctor shortage

Drug for rare kidney disease narrowly misses mark in clinical trial

Senate HELP committee spars over health care workforce policies

CDC advisers recommend seasonal use of Pfizer RSV shot

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

hotspot

explore

leisure time

focus